Literature DB >> 12403340

Complement in central nervous system inflammation.

Scott R Barnum1.   

Abstract

The complement system is well represented in the central nervous system. Glial cells and neurons produce or express all of the activation and regulatory proteins and the C3a/C5a receptors. Inhibition of complement activation is protective in experimental allergic encephalomyelitis, the animal model for multiple sclerosis, suggesting possible therapeutic approaches for human disease. New findings indicate that the C3a/C5a receptors are widely expressed in neurons and may modulate neuronal function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12403340     DOI: 10.1385/IR:26:1-3:007

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  32 in total

Review 1.  Complement components of the innate immune system in health and disease in the CNS.

Authors:  P Gasque; Y D Dean; E P McGreal; J VanBeek; B P Morgan
Journal:  Immunopharmacology       Date:  2000-08

Review 2.  Complement and innate immunity.

Authors:  W C Song; M R Sarrias; J D Lambris
Journal:  Immunopharmacology       Date:  2000-08

3.  Complement factor C5a and epidermal growth factor trigger the activation of outward potassium currents in cultured murine microglia.

Authors:  S Ilschner; C Nolte; H Kettenmann
Journal:  Neuroscience       Date:  1996-08       Impact factor: 3.590

4.  Complement C3 and factor B cerebrospinal fluid concentrations in bacterial and aseptic meningitis.

Authors:  P F Stahel; D Nadal; H W Pfister; P M Paradisis; S R Barnum
Journal:  Lancet       Date:  1997-06-28       Impact factor: 79.321

Review 5.  The role of complement and complement receptors in induction and regulation of immunity.

Authors:  M C Carroll
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

6.  Expression of C5a receptor in mouse brain: role in signal transduction and neurodegeneration.

Authors:  H Osaka; A McGinty; U E Höepken; B Lu; C Gerard; G M Pasinetti
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

7.  Cutting edge: C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis in mice.

Authors:  D M Calida; C Constantinescu; E Purev; G X Zhang; E S Ventura; E Lavi; A Rostami
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

8.  Up-regulated production and activation of the complement system in Alzheimer's disease brain.

Authors:  K Yasojima; C Schwab; E G McGeer; P L McGeer
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

9.  Binding specificity and presynaptic action of anaphylatoxin C5a in rat brain.

Authors:  N Schupf; C A Williams; A Berkman; W S Cattell; L Kerper
Journal:  Brain Behav Immun       Date:  1989-03       Impact factor: 7.217

10.  Extrahepatic secreted complement C3 contributes to circulating C3 levels in humans.

Authors:  M A Naughton; M Botto; M J Carter; G J Alexander; J M Goldman; M J Walport
Journal:  J Immunol       Date:  1996-04-15       Impact factor: 5.422

View more
  27 in total

1.  C5a-induced gene expression in human umbilical vein endothelial cells.

Authors:  Eric A Albrecht; Arul M Chinnaiyan; Sooryanarayana Varambally; Chandan Kumar-Sinha; Terrence R Barrette; J Vidya Sarma; Peter A Ward
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

Review 2.  [The relevance of the inflammatory response in the injured brain].

Authors:  O I Schmidt; I Leinhase; E Hasenboehler; S J Morgan; P F Stahel
Journal:  Orthopade       Date:  2007-03       Impact factor: 1.087

Review 3.  Neuroprotection in stroke by complement inhibition and immunoglobulin therapy.

Authors:  T V Arumugam; T M Woodruff; J D Lathia; P K Selvaraj; M P Mattson; S M Taylor
Journal:  Neuroscience       Date:  2008-07-12       Impact factor: 3.590

4.  Classical complement activation and acquired immune response pathways are not essential for retinal degeneration in the rd1 mouse.

Authors:  Bärbel Rohrer; Christina Demos; Rico Frigg; Christian Grimm
Journal:  Exp Eye Res       Date:  2006-10-25       Impact factor: 3.467

5.  Soluble membrane attack complex is diagnostic for intraventricular shunt infection in children.

Authors:  Theresa N Ramos; Anastasia A Arynchyna; Tessa E Blackburn; Scott R Barnum; James M Johnston
Journal:  JCI Insight       Date:  2016-07-07

Review 6.  [Traumatic brain injury: impact on timing and modality of fracture care].

Authors:  P F Stahel; W Ertel; C E Heyde
Journal:  Orthopade       Date:  2005-09       Impact factor: 1.087

7.  Gangliosides play pivotal roles in the regulation of complement systems and in the maintenance of integrity in nerve tissues.

Authors:  Yuhsuke Ohmi; Orie Tajima; Yuki Ohkawa; Atsushi Mori; Yasuo Sugiura; Keiko Furukawa; Koichi Furukawa
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-11       Impact factor: 11.205

8.  C5a promotes migration, proliferation, and vessel formation in endothelial cells.

Authors:  Ryuji Kurihara; Kunihiro Yamaoka; Norifumi Sawamukai; Shohei Shimajiri; Koichi Oshita; Sonosuke Yukawa; Mikiko Tokunaga; Shigeru Iwata; Kazuyoshi Saito; Kenji Chiba; Yoshiya Tanaka
Journal:  Inflamm Res       Date:  2010-03-09       Impact factor: 4.575

9.  Systemic complement activation following human acute ischaemic stroke.

Authors:  E D Pedersen; U Waje-Andreassen; C A Vedeler; G Aamodt; T E Mollnes
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

Review 10.  Immune-mediated animal models of Tourette syndrome.

Authors:  Mady Hornig; W Ian Lipkin
Journal:  Neurosci Biobehav Rev       Date:  2013-01-10       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.